Casdin Capital as of Dec. 31, 2021
Portfolio Holdings for Casdin Capital
Casdin Capital holds 53 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biolife Solutions Com New (BLFS) | 7.9 | $282M | 7.6M | 37.27 | |
| Eqrx | 7.6 | $270M | 40M | 6.82 | |
| Fate Therapeutics (FATE) | 5.6 | $199M | 3.4M | 58.51 | |
| Invitae (NVTAQ) | 5.3 | $186M | 12M | 15.27 | |
| Alnylam Pharmaceuticals (ALNY) | 4.8 | $170M | 1.0M | 169.58 | |
| Blueprint Medicines (BPMC) | 4.7 | $166M | 1.6M | 107.11 | |
| Pacific Biosciences of California (PACB) | 4.6 | $164M | 8.0M | 20.46 | |
| EXACT Sciences Corporation (EXAS) | 4.5 | $159M | 2.0M | 77.83 | |
| Somalogic Class A Com | 4.1 | $144M | 12M | 11.64 | |
| Maxcyte (MXCT) | 4.0 | $142M | 14M | 10.19 | |
| Codexis (CDXS) | 3.8 | $135M | 4.3M | 31.27 | |
| Sarepta Therapeutics (SRPT) | 3.4 | $122M | 1.4M | 90.05 | |
| Relay Therapeutics (RLAY) | 3.3 | $119M | 3.9M | 30.71 | |
| Verve Therapeutics (VERV) | 3.3 | $116M | 3.1M | 36.87 | |
| Guardant Health (GH) | 2.2 | $79M | 790k | 100.02 | |
| Agios Pharmaceuticals (AGIO) | 1.9 | $69M | 2.1M | 32.87 | |
| Tenaya Therapeutics (TNYA) | 1.9 | $68M | 3.6M | 18.95 | |
| Denali Therapeutics (DNLI) | 1.9 | $67M | 1.5M | 44.60 | |
| Beam Therapeutics (BEAM) | 1.8 | $65M | 819k | 79.69 | |
| Absci Corp (ABSI) | 1.8 | $63M | 7.7M | 8.20 | |
| Tango Therapeutics (TNGX) | 1.7 | $60M | 5.5M | 10.94 | |
| Revolution Medicines (RVMD) | 1.7 | $60M | 2.4M | 25.17 | |
| Caredx (CDNA) | 1.5 | $53M | 1.2M | 45.48 | |
| Twist Bioscience Corp (TWST) | 1.5 | $52M | 670k | 77.39 | |
| Century Therapeutics (IPSC) | 1.4 | $51M | 3.2M | 15.86 | |
| Beigene Sponsored Adr (BGNE) | 1.1 | $41M | 150k | 270.93 | |
| Allogene Therapeutics (ALLO) | 1.1 | $40M | 2.7M | 14.92 | |
| Global Blood Therapeutics In | 1.1 | $39M | 1.3M | 29.27 | |
| Ginkgo Bioworks Holdings Cl A Shs (DNA) | 1.0 | $36M | 4.3M | 8.31 | |
| Alector (ALEC) | 1.0 | $34M | 1.7M | 20.65 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.8 | $28M | 1.0M | 28.06 | |
| Dermtech Ord ord (DMTK) | 0.8 | $28M | 1.7M | 15.80 | |
| Science 37 Holdings | 0.6 | $22M | 1.8M | 12.47 | |
| Sema4 Holdings Corp Com Cl A | 0.6 | $22M | 5.0M | 4.46 | |
| Crispr Therapeutics Namen Akt (CRSP) | 0.6 | $20M | 266k | 75.78 | |
| Monte Rosa Therapeutics (GLUE) | 0.6 | $20M | 961k | 20.42 | |
| Seer Com Cl A (SEER) | 0.5 | $18M | 800k | 22.81 | |
| Magenta Therapeutics | 0.5 | $17M | 3.9M | 4.43 | |
| Singular Genomics Systems In (OMIC) | 0.5 | $17M | 1.4M | 11.56 | |
| Exscientia Ads (EXAI) | 0.4 | $14M | 714k | 19.76 | |
| 23andme Holding Class A Com (ME) | 0.3 | $12M | 1.8M | 6.66 | |
| 4d Molecular Therapeutics In (FDMT) | 0.3 | $12M | 556k | 21.94 | |
| 908 Devices (MASS) | 0.3 | $11M | 407k | 25.87 | |
| Zai Lab Adr (ZLAB) | 0.3 | $9.4M | 150k | 62.85 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 0.3 | $9.4M | 548k | 17.13 | |
| Generation Bio (GBIO) | 0.3 | $9.4M | 1.3M | 7.08 | |
| Oric Pharmaceuticals (ORIC) | 0.2 | $8.8M | 602k | 14.70 | |
| Kronos Bio (KRON) | 0.2 | $7.9M | 583k | 13.59 | |
| Decibel Therapeutics | 0.2 | $5.4M | 1.2M | 4.65 | |
| Berkeley Lts | 0.1 | $3.6M | 200k | 18.18 | |
| Stoke Therapeutics (STOK) | 0.1 | $2.9M | 120k | 23.99 | |
| Lianbio Sponsored Ads (LIANY) | 0.0 | $1.3M | 206k | 6.16 | |
| Sana Biotechnology (SANA) | 0.0 | $929k | 60k | 15.48 |
